Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DACTOLISIB Cause Therapy non-responder? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Therapy non-responder have been filed in association with DACTOLISIB. This represents 33.3% of all adverse event reports for DACTOLISIB.

6
Reports of Therapy non-responder with DACTOLISIB
33.3%
of all DACTOLISIB reports
0
Deaths
5
Hospitalizations

How Dangerous Is Therapy non-responder From DACTOLISIB?

Of the 6 reports, 5 (83.3%) required hospitalization.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DACTOLISIB. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does DACTOLISIB Cause?

Diarrhoea (10) Nausea (9) Vomiting (8) Headache (7) Hepatic pain (6) Lethargy (6) Malignant neoplasm progression (6) Pancreatic neuroendocrine tumour (6)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Related Pages

DACTOLISIB Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder DACTOLISIB Demographics